Status:

COMPLETED

Effects of Oral Pre-loads on Subsequent Energy Intake

Lead Sponsor:

University Hospital, Basel, Switzerland

Conditions:

Energy Intake

Gastrointestinal Hormones

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

The aim of this project is to investigate the effect of erythritol (given as pre-load), compared to sucrose, sucralose, and water on energy intake during a subsequent ad libitum test meal in healthy p...

Detailed Description

The subjects will participate in four study days. The screening will last 60 minutes, the study days about 4.5 hours each. After a simple-carbohydrate standard dinner, the subjects have to do an overn...

Eligibility Criteria

Inclusion

  • Healthy normal weight subjects with a body-mass index of 19.0-24.9
  • Normal eating habits (eating breakfast; no diets; no dietary changes; no vegetarians/vegans, no intolerances/allergies)
  • Age 18-55 years
  • Stable body weight (+/- 5%) for at least three months
  • Informed Consent as documented by signature (Appendix Informed Consent Form)

Exclusion

  • Shift worker
  • Fructose intolerance
  • Pre-existing consumption of erythritol and/or sucralose more than once a week
  • Substance abuse
  • Regular intake of medications, except anticontraceptive
  • Chronic or clinically relevant acute infections
  • Pregnancy: although no contraindication, pregnancy might influence metabolic state. Women who are pregnant or have the intention to become pregnant during the course of the study are excluded. Female participants of childbearing age have to use safe contraception (oral, injectable, or implantable contraceptives, intrauterine contraceptive devices, or tubectomy). In female participants a urine pregnancy test is carried out upon screening.
  • Participation in another study with investigational drug within the 30 days preceding and during the present study.

Key Trial Info

Start Date :

February 5 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 3 2021

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04713137

Start Date

February 5 2021

End Date

June 3 2021

Last Update

December 16 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Claraspital

Basel, Switzerland, 4002